Exelixis Inc [EXEL] stock is trading at $26.50, up 0.76%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EXEL shares have gain 1.69% over the last week, with a monthly amount glided 2.59%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on September 19, 2024, when UBS initiated its Neutral rating and assigned the stock a price target of $30. Previously, Barclays downgraded its rating to Equal Weight on April 11, 2024, and kept the price target unchanged to $25. On December 19, 2023, BTIG Research initiated with a Buy rating and assigned a price target of $27 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $31 on December 15, 2023. H.C. Wainwright initiated its recommendation with a Buy and recommended $28 as its price target on September 26, 2023. Oppenheimer reiterated a Outperform rating for this stock on August 22, 2023, and upped its price target to $29. In a note dated August 08, 2023, SVB Securities initiated an Market Perform rating and provided a target price of $18 on this stock.
Exelixis Inc [EXEL] stock has fluctuated between $18.64 and $27.83 over the past year. Currently, Wall Street analysts expect the stock to reach $28.45 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $26.50 at the most recent close of the market. An investor can expect a potential return of 7.36% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Exelixis Inc [NASDAQ:EXEL] reported sales of 2.01B for the trailing twelve months, which represents a growth of 35.61%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.16 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.07 points at the first support level, and at 25.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.73, and for the 2nd resistance point, it is at 26.95.
Ratios To Look Out For
For context, Exelixis Inc’s Current Ratio is 4.27. Further, the Quick Ratio stands at 4.21, while the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 3.75, the price to book ratio is 3.57 and price to earnings (TTM) ratio is 22.69.
Transactions by insiders
Recent insider trading involved Hessekiel Jeffrey, EVP & General Counsel, that happened on Sep 23 ’24 when 25000.0 shares were sold. Officer, JEFFREY J HESSEKIEL completed a deal on Sep 23 ’24 to buy 75000.0 shares. Meanwhile, EVP, General Counsel & Sec Hessekiel Jeffrey sold 20000.0 shares on Aug 26 ’24.
